Introduction {#s1}
============

Angelicae Pubescentis Radix (equivalent to Angelica Pubescens Root, known as "Duhuo" in China, "Dokwhal" in Korea, "Dokkatsu" in Japan) has been used as herbal medicine extensively since ancient times in Asian countries, including China, Korea and Japan. Due to its effective medicinal value, it has been included in Chinese Pharmacopoeia, British Pharmacopoeia, European Pharmacopoeia, and so on. As an antirheumatic and analgesic agent, it is commonly used as a traditional Chinese medicine (TCM) to treat rheumatic arthralgia and headache. Rheumatic arthralgia is the professional description of TCM syndrome, and includes clinical symptoms such as muscle and joint pain, joint deformities, and dysfunction, with resulting exhaustion and lack of strength. These symptoms are common in rheumatic diseases such as rheumatism and rheumatoid arthritis (RA), with modern medicine ascribing them to an immune deficiency ([@B60]). In addition, APR is also used in the field of health-care products and cosmetics.

From the Chinese Pharmacopoeia (version 1977), Angelicae Pubescentis Radix (APR) is the dried roots of *Angelica biserrata* (R.H.Shan & C.Q.Yuan) C.Q.Yuan & R.H.Shan (a synonym for *Angelica pubescens* f. *biserrata* R.H. Shan & C.Q. Yuan in Chinese Pharmacopoeia). Besides, *Angelica pubescens* Maxim used to be a plant source of APR in China, and it is still a medicinal plant in Japan. In this review, *A. biserrata* and *A. pubescens* will be reviewed collectively.

APR is mainly produced in Sichuan, Hubei, Anhui and other provinces in China. Usually, its excavation takes place in early spring or late fall. It is common to remove the fibrous roots and sediment, half dried above the heated mud. They were piled for 2 to 3 days, then heated to dry absolutely when they become soft. To date, 87 compounds, including coumarins, polyene-alkynes, phenolic acids, steroids, nucleoside elements have been isolated and identified from APR. What\'s more, nearly 100 volatile oil compounds have been analyzed by GC-MS. In modern clinical practice, APR plays an important role in treating RA, osteoarthritis pain, vascular dementia (VD), Alzheimer\'s disease (AD) and headache ([@B62]; [@B25]; [@B93]).

In this review, we discussed the botany, traditional medicinal use, phytochemistry, pharmacology, pharmacokinetic, toxicology and quality control of APR as comprehensively as possible, to obtain a comprehensive understanding of the effects of APR and also provide a basis for further research and development of new drugs.

Botany {#s2}
======

*Angelica biserrata* (R.H.Shan & C.Q.Yuan) C.Q.Yuan & R.H.Shan (*A. biserrata*, Chinese name: Chongchi Maodanggui) and *Angelica pubescens* Maxim (*A. pubescens*, Chinese name: Maodanggui) used to be or still be medicinal plants of APR. At present, *A. biserrata* is the plant source of APR recorded in multi-national pharmacopoeia, including Chinese, British, the European. *A. pubescens*, which used to be a medicinal plant for APR in China, is mainly produced in Japan and is used medically in that country at present ([@B94]; [@B55]). In the following discussion, *A. biserrata* and *A. pubescens* will be reviewed collectively.

*A. biserrata* and *A. pubescens* both belong to the genus *Angelica* of the family *Apiaceae*, and the former is a variant of the latter. Due to too much similarity of the plants and constant errors in the study of the resources, some of the *A. biserrata* were once mistaken for *A. pubescens* before the 1990s. According to the resource survey, there is no such a species as *A. pubescens* in China ([@B24]; [@B56]). It has been concluded that *A. biserrata* is primarily distributed in China South-Central, China Southeast, and Vietnam, while *A. pubescens* is primarily distributed in Japan and Vietnam (<http://www.plantsoftheworldonline.org/>).

*A. biserrata* primarily grows on wet and damp slopes, under the forest grass, or in sparse shrubs in Sichuan, Hubei, Jiangxi, Anhui, and Zhejiang provinces, among other selected regions. It is also cultivated in the high mountains of the Sichuan, Hubei, and Shanxi provinces, and breeding methods include seed breeding, direct seeding, and the transplanting of seedlings. In terms of *A. biserrata*, the medicinal material shape of the cultivated variety is similar to the wild product, but the root of the cultivated product is large and soft, with a length of 10--20 cm, and a strong fragrance (<http://frps.iplant.cn/>; [@B75]).

The description of *A. biserrata* and *A. pubescens* plants morphology as referenced by the Flora of China (FOC) and Flora of Japan (FOJ) is presented in [**Table 1**](#T1){ref-type="table"}. The whole plant of *A. biserrata* ([**Figure 1A**](#f1){ref-type="fig"}), medicinal parts of APR ([**Figure 1B**](#f1){ref-type="fig"}), and the processed of APR ([**Figure 1C**](#f1){ref-type="fig"}) are shown in [**Figure 1**](#f1){ref-type="fig"}. To further distinguish the two plants, the comparison between them were performed based on scientific synonyms included in Kew\'s taxonomic resources and names published in medicinal references, and the results are shown in [**Table 2**](#T2){ref-type="table"}.

###### 

The Characteristics and Distribution of medicinal plants as APR.

  Scientific name                                                                                                                Chinese name                    Characteristics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Distribute                                                                                                  Reference
  ------------------------------------------------------------------------------------------------------------------------------ ------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------- -------------------------------------------------------
  *Angelica biserrata* (R.H. Shan & C.Q. Yuan) C.Q. Yuan & R.H. Shan/*Angelica pubescens* f. *biserrata* R.H. Shan & C.Q. Yuan   Chongchi Maodanggui重齿毛当归   Plants perennial, 1-2 m, stout. Root cylindric, brown, up to 15 × 1--2.5 cm, aromatic. Stem purplish green, up to 1.5 cm thick, thinly ribbed, hispid above. Basal and lower leaves petiolate, sheaths oblong, inflated, glabrous or slightly pubescent abaxially; blade broad-ovate, 2-ternate-pinnate; leaflets ovate-long-elliptic, base often decurrent along rachis, margin irregularly cuspidate-biserrate, apex acuminate, pubescent along nerves and margin. Peduncles, densely hispidulous; bracts 1, long-subulate, ciliate, deciduous; bracteoles 5--10, broad-lanceolate, apex long-cuspidate, ciliate, pubescent abaxially; umbellules flowered. Calyx teeth obsolete. Petals white, obovate.   Sparse shrubby thickets, damp slopes; Sichuan, Hubei, Jiangxi, Anhui, Zhejiang, Shanxi, Chongqing, Gansu.   FOC[^a^](#fnT1_1){ref-type="table-fn"} (version 2004)
  *Angelica pubescens* Maxim.                                                                                                    Maodanggui毛当归                Stems stout, green, terete, 1--2 m. long, sparingly pubescent; leaves large, about thrice ternately pinnate, the leaflets ovate to elliptic, 5--10 cm. long, sometimes oblong, abrupdy acuminate, often decurrent at base, acutely dentate, pale green beneath, the upper leaves much reduced, with obovate, inflated sheaths; umbels rather numerous, the bracts and bractlets lacking, the rays numerous, 3--16 cm. long, puberulent, the pedicels 25--40, slender. long, puberulent; 2--6 on the commissure, the styles short, shorter than the stylopodium.                                                                                                                                              Hills and low mountains; Honshu, Shikoku, Kyushu; rather variable.                                          FOJ[^b^](#fnT1_2){ref-type="table-fn"} (version 1965)

Cited from the website: <http://foc.iplant.cn/>.

Cited from the website: <https://www.ndl.go.jp/>.

APR, Angelicae Pubescentis Radix.

![The whole plant of *A. biserrata* **(A)**, medicinal parts of APR **(B)**, the processed of APR **(C)**.](fphar-11-00335-g001){#f1}

###### 

Scientific synonyms and names published in medicinal references of medicinal plants as APR.

  Scientific name                                                      No.                            Scientific synonyms                                         No.                                                               Names published in medicinal references
  -------------------------------------------------------------------- ------------------------------ ----------------------------------------------------------- ----------------------------------------------------------------- --------------------------------------------------------------------
  *Angelica biserrata* (R.H. Shan & C.Q. Yuan) C.Q. Yuan & R.H. Shan   1                              *Angelica pubescens* f. *biserrata* R.H. Shan & C.Q. Yuan   1                                                                 *Angelica biserrata (*R.H. Shan & C.Q. Yuan) C.Q. Yuan & R.H. Shan
                                                                                                      2                                                           *Angelica biserrata* (Shan et Yuan) Yuan et Shan                  
                                                                                                      3                                                           *Angelica pubescens* Maxim. f. *biserrata* R.H.Shan et C.Q.Yuan   
                                                                                                      4                                                           *Angelica pubescens* Maxim. f*. biserrata* Shan et Yuan           
  *Angelica pubescens* Maxim.                                          1                              *Angelica myriostachys* Koidz.                              1                                                                 *Angelica pubescens* Maxim.
  2                                                                    *Angelica polyclada* Franch.   2                                                           *Angelica pubescens*                                              
  3                                                                    *Angelica schishiudo* Koidz.   3                                                           *Angelica polyclada* Franchet                                     
                                                                                                      4                                                           *Angelica pubescens* Maximowicz                                   

Cited from the website: <https://mpns.science.kew.org/mpns-portal/>.

APR, Angelicae Pubescentis Radix.

Traditional Medicinal Use {#s3}
=========================

APR is widely used as the important traditional Chinese medicine to treat rheumatic arthralgia and headache for nearly 2000 years. In the Chinese Pharmacopoeia (version 2015), it has been used to treat conditions such as wind-cold-dampness arthralgia, lumbar and knee pain, wind-cold dampness headache, and its recommended dosage is 3--10 g ([@B8]).

According to TCM records, APR was initially recorded in "Shen Nong Ben Cao Jing" during the Eastern Han Dynasty (perhaps earlier), which is deemed as the earliest treatise for medicine in China. In this monograph, APR was described as a treatment for wind-cold blows, gold sore pain and hernia mass in women. In "Ben Cao Gang Mu", another monograph of TCM, APR was described as a treatment to resist stroke, joint pain, tooth swelling and pain by wind. In ancient times, the long-term clinical application was primarily the function of expelling wind and removing dampness, thus relieving pain and exterior syndrome, acting as an antispasmodic, suppressing the hyperactive liver for calming endogenous wind, flattening the Qi, and lowering the inverse to stop vomiting, relieving itching, detoxifying, and inducing hemostasis ([@B89]).

In addition, APR also has been used with other herbs to treat wind-cold exterior syndrome (TCM term: Fenghan Biaozheng, also can be interpreted as superficial syndrome due to wind-cold), and wind-cold-damp bi-syndromes (TCM term: Fenghanshi Bizheng, also can be interpreted as painful obstructions from wind, damp, and cool environments) in China since ancient times. For example, Duhuo Tang consists of APR together with Angelicae Sinensis Radix, Atractylodis Macrocephalae Rhizoma, Astragali Radix, Cinnamomi Cortex, Achyranthis Bidentatae Radix, and Glycyrrhizae Radix et Rhizoma and can be used to treat rheumatic arthralgia ([@B15]). In addition, it was reported that Duhuo Jisheng Tang was effective in treating arthralgia syndrome in the 1990s in Germany ([@B97]). Many classic prescriptions had been created by the ancient famous doctors and have been handed down from generation to generation through repeated clinical verification for thousands of years. Due to its definite clinical effects, TCM prescriptions are the main form of TCM used in clinics. The combination of several different types of TCM can enhance efficacy and reduce adverse reactions.

The application of APR in the field of health care has a long history. Early in "Shen Nong Ben Cao Jing", there is a record that it can make the body light and slow down your aging. There are also a variety of ways to eat APR, such as Duhuo tea recorded in "Yao Cha Zhi Bai Bing", Duhuo Renshen wine recorded in "Tai Ping Sheng Hui Fang", and Duhuo Danggui wine recorded in "Sheng Ji Zong Lu". In recent years, the application of APR to the field of health care has been further developed, and there have been multiple patent authorizations for inventions, such as a types of APR to dispel wind and dehumidify hot pot material, types of production methods ([@B70]), treating a kind of internal injury fever, and APR health wine ([@B54]).

In addition to the above application areas, APR has entered the field of beauty and makeup, and has been granted a number of invention patents, such as APR grass oil emollient water ([@B69]), and the preparation methods for APR oil tea emulsion ([@B38]).

Phytochemistry {#s4}
==============

At present, many chemical compounds, including coumarins, polyene-alkynes, phenolic acids, steroids, nucleoside elements, and others, have been isolated and identified from *A. biserrata* and *A. pubescens*. Among these, Coumarins are believed to be the principle non-volatile ingredients with important biological properties. In addition, nearly 100 volatile oil compounds, consisting of terpenoids, small molecular aliphatic and aromatic compounds, have been analyzed by GC-MS ([@B78]; [@B63]). The name, molecular formula, precise mass, and the source of these compounds are listed in [**Table 3**](#T3){ref-type="table"}. The relevant structures of these compounds are shown in [**Figures 2**](#f2){ref-type="fig"} and [**3**](#f3){ref-type="fig"}.

###### 

Chemical constituents isolated from medicinal plants as APR.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.                   Compound                                                                                     Molecular\           Precise Mass   Source                                                      References
                                                                                                                     Formula                                                                                         
  --------------------- -------------------------------------------------------------------------------------------- -------------------- -------------- ----------------------------------------------------------- ----------------
  **COUMARINS**                                                                                                                                                                                                      

  **1**                 Angelitriol                                                                                  C~15~H~18~O~6~       294.1103       Root & rhizome of *A. biserrata*                            [@B42]; [@B44]

  **2**                 Anpubesol                                                                                    C~20~H~26~O~7~       378.1679       Root of *A. biserrata*                                      [@B52]

  **3**                 Angelol A (Angelol)                                                                          C~20~H~24~O~7~       376.1522       Root of *A. pubescens*; Root & rhizome of *A. biserrata*    [@B19]; [@B45]

  **4**                 Angelol B                                                                                    C~20~H~24~O~7~       376.1522       Root of *A. pubescens*; Root & rhizome of *A. biserrata*    [@B2]; [@B45]

  **5**                 Angelol C                                                                                    C~20~H~26~O~7~       378.1679       Root of *A. pubescens*; Root & rhizome of *A. biserrata*    [@B2]; [@B45]

  **6**                 Angelol D                                                                                    C~20~H~24~O~7~       376.1522       Root of *A. pubescens*; Root & rhizome of *A. biserrata*    [@B2]; [@B45]

  **7**                 Angelol E                                                                                    C~20~H~26~O~7~       378.1679       Root of *A. pubescens*; Root & rhizome of *A. biserrata*    [@B2]; [@B45]

  **8**                 Angelol F                                                                                    C~20~H~26~O~7~       378.1679       Root of *A. pubescens*; Root & rhizome of *A. biserrata*    [@B2]; [@B45]

  **9**                 Angelol G                                                                                    C~20~H~24~O~7~       376.1522       Root of *A. pubescens*; Root & rhizome of *A. biserrata*    [@B2]; [@B45]

  **10**                Angelol H                                                                                    C~20~H~26~O~7~       378.1679       Root of *A. pubescens*                                      [@B2]

  **11**                Angelol I                                                                                    C~20~H~26~O~7~       378.1679       Root & rhizome of *A. biserrata*                            [@B45]

  **12**                Angelol J                                                                                    C~17~H~22~O~6~       322.1416       Root & rhizome of *A. biserrata*                            [@B42]; [@B45]

  **13**                Angelol K                                                                                    C~20~H~24~O~7~       376.1522       Root of *A. biserrata*                                      [@B43]; [@B45]

  **14**                Angelol L                                                                                    C~20~H~26~O~7~       378.1679       Root of *A. biserrata*                                      [@B43]; [@B45]

  **15**                Isoangelol                                                                                   C~24~H~24~O~7~       376.1522       Root of *A. biserrata*                                      [@B52]

  **16**                Umbelliferone                                                                                C~9~H~6~O~3~         162.0317       Fruit of *A. pubescens*; Root & rhizome of *A. biserrata*   [@B21]; [@B41]

  **17**                Osthole (Osthol)                                                                             C~15~H~16~O~3~       244.1099       Fruit of *A. pubescens*; Root of *A. pubescens*             [@B19]; [@B21]

  **18**                Osthenol                                                                                     C~14~H~14~O~3~       230.0943       No mentioned                                                [@B66]

  **19**                2\'-deoxymeranzin hydrate                                                                    C~15~H~18~O~4~       262.1205       Root of *A. biserrata*                                      [@B90]

  **20**                Meranzin hydrate                                                                             C~15~H~18~O~5~       278.1154       Root & rhizome of *A. biserrata*                            [@B44]

  **21**                Scopoletin                                                                                   C~10~H~8~O~4~        192.0423       Fruit of *A. pubescens*                                     [@B21]

  **22**                7-methoxy-6-coumarinaldehyde (Angelical)                                                     C~11~H~8~O~4~        204.0423       Root of *A. pubescens*                                      [@B20]

  **23**                Ulopterol                                                                                    C~15~H~18~O~5~       278.1154       Root & rhizome of *A. biserrata*                            [@B41]

  **24**                Peucedanol                                                                                   C~14~H~16~O~5~       264.0988       Root & rhizome of *A. biserrata*                            [@B41]

  **25**                7-*O*-*β*-D-glucopyranosyl-umbelliferone                                                     C~15~H~16~O~8~       324.0845       Root & rhizome of *A. biserrata*                            [@B10]

  **26**                7-*O*-*β*-D-apiofuranosyl-(1→6)-*β*-D-glucopyranosyl-umbelliferone                           C~20~H~24~O~12~      456.1268       Root & rhizome of *A. biserrata*                            [@B10]

  **27**                6-*O*-*β*-D-apiofuranosyl-(1→6)-*β*-D-glucopyranosyl-scopoletin                              C~20~H~24~O~13~      472.1217       Root & rhizome of *A. biserrata*                            [@B10]

  **28**                5-isopentenyloxy-7-methoxy-8-senecioylcoumarin (Angelin)                                     C~20~H~22~O~5~       342.1467       Root of *A. pubescens*                                      [@B31]

  **29**                Coumurrayin                                                                                  C~16~H~18~O~4~       274.1205       Root of *A. pubescens*                                      [@B31]

  **30**                7-methoxy-8-senecioylcoumarin                                                                C~15~H~14~O~4~       258.0892       Root of *A. pubescens*                                      [@B31]

  **31**                8-(3-hydroxyisovaleroyl)-5,7-dimethoxycoumarin                                               C~16~H~18~O~6~       306.1103       Root of *A. pubescens*                                      [@B31]

  **32**                Glabra-lactone                                                                               C~16~H~16~O~5~       288.0998       Fruit of *A. pubescens;* Root of *A. pubescens*             [@B19]; [@B21]

  **33**                Umbelliprenin                                                                                C~24~H~30~O~3~       366.2195       Fruit of *A. pubescens*                                     [@B21]

  **34**                Apiosylskimmin                                                                               C~20~H~24~O~12~      456.1268       Root & rhizome of *A. biserrata*                            [@B41]

  **35**                Angepubebisin                                                                                C~23~H~28~O ~7~      416.1835       Root of *A. biserrata*                                      [@B80]

  **36**                Isoangelol dehydration                                                                       C~20~H~22~O~6~       358.1416       Not mentioned                                               [@B66]

  **37**                Angelol A dehydration                                                                        C~20~H~22~O~6~       358.1416       Not mentioned                                               [@B66]

  **38**                Anpubesol dehydration                                                                        C~20~H~24~O~6~       360.1573       Not mentioned                                               [@B66]

  **39**                Angelol C dehydration                                                                        C~20~H~24~O~6~       360.1573       Not mentioned                                               [@B66]

  **40**                Columbianadin                                                                                C~19~H~20~O~5~       328.1311       Root of *A. biserrata*                                      [@B61]

  **41**                Columbianetin acetate                                                                        C~16~H~16~O~5~       288.0998       Root of *A. biserrata*                                      [@B61]

  **42**                Columbianetin propionate                                                                     C~17~H~8~O~5~        302.1154       Root of *A. biserrata*                                      [@B46]

  **43**                Columbianetin                                                                                C~14~H~14~0~4~       246.0892       Root of *A. biserrata*                                      [@B61]

  **44**                Columbianetin-*β*-D-glucopyranoside                                                          C~20~H~24~O~9~       394.1264       Root & rhizome of *A. biserrata*                            [@B33]; [@B73]

  **45**                Columbianin                                                                                  C~26~H~34~O~14~      570.1949       Root & rhizome of *A. biserrata*                            [@B44]

  **46**                2\'-(1", 2", 3"-three hydroxyl)-isoamyl Angelica lactone                                     C~16~H~18~O~7~       322.1053       Root of *A. biserrata*                                      [@B73]

  **47**                Angelidiol(heramandiol)                                                                      C~14~H~14~O~5~       262.0841       Root & rhizome of *A. biserrata*                            [@B40]; [@B44]

  **48**                Angenomalin                                                                                  C~14~H~12~O~3~       228.0786       Root of *A. biserrata*                                      [@B79]

  **49**                Dihydrocolumbianadin                                                                         C~19~H~22~O~5~       330.1467       Root of *A. biserrata*                                      [@B66]

  **50**                Isobergapten                                                                                 C~12~H~8~O~4~        216.0423       Root of *A. biserrata*                                      [@B58]

  **51**                Psoralen                                                                                     C~11~H~6~O~3~        186.0317       Fruit of *A. pubescens*; Root of *A. biserrata*             [@B21]; [@B90]

  **52**                Bergapten                                                                                    C~12~H~8~O~4~        216.0423       Fruit & root of *A. pubescens*                              [@B19]; [@B21]

  **53**                Bergaptol                                                                                    C~11~H~6~O~4~        202.0266       Root of *A. biserrata*                                      [@B90]

  **54**                Imperatorin                                                                                  C~16~H~14~O~4~       270.0892       Root of *A. biserrata*;\                                    [@B21]; [@B58]
                                                                                                                                                         Fruit of *A. pubescens*                                     

  **55**                Isoimperatorin                                                                               C~16~H~14~O~4~       270.0892       Root of *A. biserrata*                                      [@B52]; [@B66]

  **56**                Oxypeucedanin hydrate                                                                        C~16~H~16~O~6~       304.0947       Root & rhizome of *A. biserrata*                            [@B41]

  **57**                Xanthotoxin                                                                                  C~12~H~8~O~4~        216.0423       Fruit of *A. pubescens*; Root of *A. biserrata*             [@B21]; [@B52]

  **58**                Isopimpinellin                                                                               C~13~H~10~O~5~       246.0528       Root of *A. pubescens*                                      [@B31]

  **59**                Byak-angelicin                                                                               C~17~H~18~O~7~       334.1053       Root of *A. pubescens*                                      [@B31]

  **60**                5-methoxy-8-(2-acethoxy-3-hydroxy-3-methylbutoxy) psoralen \[sec-*O*-acetylbyakangelicin\]   C~19~H~20~O~8~       376.1158       Fruit of *A. pubescens*                                     [@B21]

  **61**                Neobyakangelicol                                                                             C~17~H~16~O~6~       316.0947       Fruit of *A. pubescens*                                     [@B21]

  **62**                Cnidilin                                                                                     C~17~H~16~O~5~       300.0998       Root of *A. biserrata*                                      [@B86]

  **63**                Oxypeucedanin                                                                                C~16~H~14~O~5~       286.0841       Fruit of *A. pubescens*                                     [@B21]

  **64**                Ferulin                                                                                      C~17~H~16~O~6~       316.0947       Fruit of *A. pubescens*                                     [@B21]

  **65**                Angelmarin                                                                                   C~23~H~20~O~6~       392.1260       Rhizome of *A. biserrata*                                   [@B1]

  **66**                *Sec*-*O*-*β*-D-glucopyranosyl-(R)-byakangelicin                                             C~23~H~28~O~12~      496.1581       Root of *A. biserrata*                                      [@B9]

  **67**                *Tert*-*O*-*β*-D-glucopyranosyl-(R)-byakangelicin                                            C~23~H~28~O~12~      496.1581       Root of *A. biserrata*                                      [@B9]

  **68**                Marmesinin                                                                                   C~20~H~24~O~9~       408.1420       Root & rhizome of *A. biserrata*                            [@B44]

  **69**                Nodakenetin                                                                                  C~14~H~14~O~4~       246.0892       Root & rhizome of *A. biserrata*                            [@B44]

  **70**                Nodakenin                                                                                    C~20~H~24~O~9~       408.1420       Root & rhizome of *A. biserrata*                            [@B41]

  **POLYENE-ALKYNES**                                                                                                                                                                                                

  **71**                Falcarindiol                                                                                 C~17~H~24~O~2~       260.1776       Root of *A. biserrata*                                      [@B46]

  **72**                11(S),16(R)-dihydroxy-octadeca-9Z,17-dien-12,14-diyn-1-yl acetate                            C~20~H~28~O~4~       322.1988       Root of *A. biserrata*                                      [@B46]

  **PHENOLIC ACIDS**                                                                                                                                                                                                 

  **73**                3-*O*-*trans*-coumaroylquinic acid                                                           C~16~H~18~O~8~       338.1002       Root of *A. biserrata*                                      [@B79]

  **74**                3-*O*-*trans*-feruloylquinic acid                                                            C~17~H~20~O~9~       368.1107       Root of *A. biserrata*                                      [@B79]

  **75**                Ferulic acid                                                                                 C~10~H~10~O~4~       194.0579       Root of *A. biserrata*                                      [@B58]

  **STEROIDS**                                                                                                                                                                                                       

  **76**                Daucosterol                                                                                  C~35~H~60~O~6~       576.4390       Root & rhizome of *A. biserrata*                            [@B41]

  **77**                *β*-sitosterol                                                                               C~29~H~50~O          414.3862       Root & rhizome of *A. biserrata*                            [@B40]

  **OTHERS**                                                                                                                                                                                                         

  **78**                Adenosine                                                                                    C~10~H~13~N~5~O~4~   267.0968       Root & rhizome of *A. biserrata*                            [@B41]; [@B58]

  **79**                Uridine                                                                                      C~9~H~12~N~2~O~6~    243.0632       Root of *A. biserrata*                                      [@B58]

  **80**                Bisabolangelone                                                                              C~15~H~20~O~3~       248.1412       Root of *A. biserrata & A. pubescens*                       [@B46]

  **81**                2,3,4,9-Tetrahydro-1H-pyrido\[3,4-b\] indole-3-carboxylic acid                               C~12~H~12~N~2~O~2~   216.0899       Root & rhizome of *A. biserrata*                            [@B41]

  **82**                Sucrose                                                                                      C~12~H~22~O~11~      342.1162       Root & rhizome of *A. biserrata*                            [@B41]

  **83**                Angepubefurin                                                                                C~19~H~30~O~4~       322.2144       Root of *A. biserrata*                                      [@B80]

  **84**                Rutin                                                                                        C~27~H~30~O~16~      610.1534       Root of *A. biserrata*                                      [@B83]

  **85**                *γ*-aminobutyric acid                                                                        C~4~H~9~NO~2~        103.0633       Root & rhizome of *A. biserrata*                            [@B32]

  **86**                Angesesquid A                                                                                C~15~H~22~O~5~       280.1675       Root of *A. biserrata*                                      [@B37]

  **87**                Angesesquid B                                                                                C~15~H~22~O~5~       280.1675       Root of *A. biserrata*                                      [@B37]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

APR, Angelicae Pubescentis Radix.

![Structures of coumarins **(1--70)** isolated from medicinal plants as APR.](fphar-11-00335-g002){#f2}

![Structures of polyene-alkynes **(71, 72)**, phenolic acids **(73--75)**, steroids **(76--77)** and others **(78--87)** isolated from medicinal plants as APR.](fphar-11-00335-g003){#f3}

Coumarins {#s4_1}
---------

Coumarins are phenolic compounds characterized by a benzene ring attached to an alpha-pyrone ring, which can be regarded as a lactone formed by the dehydration of o-hydroxy cinnamic acid. Coumarins have a fragrant smell and occur naturally in many plants. In addition, they are known to possess a myriad of pharmacological activities, including antioxidant, anti-cancer, and anticoagulant effects. They are also known to be fluorophores with their fluorescence changing drastically with varying substituents and newly introduced positions. Therefore, coumarins can be identified using fluorescence detection ([@B51]). So far, the coumarins separated from APR are mainly composed of simple coumarin as the parent nucleus, linear furocoumarin formed by substitution of seven and six positions, and flavonocoumarin formed by substitution of seven and eight positions. Simple coumarins, angular furocoumarins, psoralen furocoumarins, and nodakenetin furocoumarins have been isolated and identified, with the chemical structures of these coumarins shown in [**Table 3**](#T3){ref-type="table"} and [**Figure 2**](#f2){ref-type="fig"}.

Simple coumarins (**1**--**39**) have one or more substituents at five, six, seven, eight sites in the mother nucleus of coumarin, which are replaced by -OH, -OCH~3~, etc. Some (**25--27**) can be glycosylated with sugar. Structures of the simple coumarins are shown in [**Figure 2**](#f2){ref-type="fig"}.

At present, there are 11 angular furocoumarin (**40**--**50**, **65**) compounds that have been reported. They can be divided into two types, with one type (**40--49**, **65**) having a single bond at the position of 1\' and 2\', while the other type (**50**) has a double bond. Two (**44**, **45**) of them are glycosylated. Their structures are shown in [**Figure 2**](#f2){ref-type="fig"}.

Currently, 15 psoralen furocoumarins (**51--64**, **66, 67**) have been reported, all of which have the skeleton characteristics of psoralen. The side chains of two compounds (**62**, **64**) have an epoxy structure, the other two (**63**, **64**) are glycosylated, and the remaining 11 compounds are typical psoralen furocoumarins. Their structures are shown in [**Figure 2**](#f2){ref-type="fig"}.

There are reported 3 nodakenetin furocoumarins (**68--70**) currently. The difference in these compounds from the psoralen structure is the hydrogenation of the double bonds on the furan ring. Their structures are shown in [**Figure 2**](#f2){ref-type="fig"}.

Polyene-Alkynes {#s4_2}
---------------

Two long chain polyene-alkynes (**71**, **72**) have been isolated from the root of *A. biserrata*, and they have conjugated systems with multiple double bonds and alkyne bonds. Falcarindiol (**71**) has been reported to be an anesthetic with antifungal activity. It also exhibits prominently inhibitory effects on 5-LO with an IC~50~ value of 9.4 μM, and moderate inhibitory activity on COX-1 with an IC~50~ value of 66 μM ([@B46]). The chemical structures of the polyene-alkynes are shown in [**Figure 3**](#f3){ref-type="fig"}.

Phenolic Acids {#s4_3}
--------------

Three phenolic acids (**73--75**) have been isolated from the root of *A. biserrata*. Since phenolic hydroxyl groups replace their structure, these compounds are unstable and thus easily transformed by water, temperature, light, enzymes, acids, and alkalis ([@B39]). The chemical structures of the phenolic acids are shown in [**Figure 3**](#f3){ref-type="fig"}.

Steroids {#s4_4}
--------

Two steroids (**76**, **77**) have been isolated from the root and rhizome of *A. biserrata*. They represent fused tetracyclic compounds composed of three hexacyclohexane (A, B, C) and a five-carbon ring (D). In addition, *β*-sitosterol (**77**) is a phytosterol that is common in higher plants. The chemical structures of the steroids are shown in [**Figure 3**](#f3){ref-type="fig"}.

Other Compounds {#s4_5}
---------------

Apart from the ingredients above, other compounds have been isolated and identified from *A. biserrata* and *A. pubescens*. Two nucleosides, including adenosine (**78**) and uridine (**79**), have been isolated from the root or rhizome of *A. biserrata*. Bisabolangelone (**80**) has been isolated from *A. pubescens* for the first time with strong anti-feeding properties against insects but it\'s been reported to be unstable in both basic and acidic media ([@B46]). In addition, 2, 3, 4, 9-Tetrahydro-1H-pyrido \[3, 4-b\] indole-3-carboxylic acid (**81**) and Sucrose (**82**) were isolated from the plant for the first time in 1994 ([@B41]). A new furan, angepubefurin (**83**), was determined by HR-FTICR-MS and X-ray diffraction analyses ([@B80]). Rutin (**84**) and *γ*-aminobutyric acid (**85**) have also been isolated and identified in succession ([@B32]; [@B83]). Both new sesquiterpenoid derivatives (**86**) and (**87**) could moderately inhibit the inflammatory reaction. The beneficial elements Ca, Mg, and K in APR have been determined by LIBS spectra and the artificial neural network method ([@B67]). The chemical structures of other compounds are shown in [**Figure 3**](#f3){ref-type="fig"}.

Pharmacology {#s5}
============

The study of pharmacological activities has indicated that APR has proven to have positive effects as an analgesic and anti-inflammatory agent, which are important for RA treatment strategies. Other reported functions of APR include effects on the central nervous system, effects on the cardiovascular system, deworming activity. The main pharmacological activities of the extracts or isolated compounds from APR that have been reported in animal and *in vitro* studies are summarized in [**Table 4**](#T4){ref-type="table"}.

###### 

The pharmacological activities of APR extracts or certain ingredients.

  Compounds or extracts                                                                           Assay                                                                                                                                                             Effect                                                                                                                                                                                                                  Reference
  ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------
  **ANALGESIC AND ANTI-INFLAMMATORY ACTIONS**                                                                                                                                                                                                                                                                                                                                                                                                                                               
  CRAB (1.10 g/ml)                                                                                Male SD rats; SNI model of neuropathic pain; 20 mg/kg/d *i.g.*, 14 d                                                                                              Levels of TNF-*α*, IL-1*β* and IL-6↓, expression of TRPV1 and pERK↓; ID~50~: 10.28 mg/kg                                                                                                                                [@B35]
  Columbianetin                                                                                   LPS-stimulated human peripheral blood mononuclear cell model, *in vitro*; 0, 10, 20, 40 μg/ml, 4 h                                                                TNF-*α*, IL-6, MCP-1, and IL-1*β*↓, activity of NOD1, RIP2, and NF-*κβ*↓, NOD1/NF-*κβ* pathways were blocked by ML130                                                                                                   [@B48]
  ERAB (0.82 g/ml)                                                                                LPS-induced inflammation model, *in vitro*; 1, 5, 25 mg/L, 6 h                                                                                                    Activity of NAAA↓, PEA↑, TNF-*α*, iNOS and IL-6↓, TNF-*α*, NO↓                                                                                                                                                          [@B57]
  **EFFECTS ON THE CENTRAL NERVOUS SYSTEM**                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  WRAB (0.365 g/ml)                                                                               Male Wister rats; Rat model of AD induced by intracerebral injection of A*β* ~1-40~; 2 ml/d *i.g.*, 28 d                                                          IL-4↑, TNF-*α*↓                                                                                                                                                                                                         [@B95]
  WRAB                                                                                            Male Wister rats; Rat model of AD induced by intracerebral injection of A*β*~1-40~; 2 ml/d *i.g.*, 28 d                                                           Expression of p38 mitogen-activated protein kinases↓                                                                                                                                                                    [@B88]
  WRAB and ARAB (1.10 g/ml)                                                                       Male and female Kunming mice; D-galactose brain aging model; 2.7, 8.1, 24.3 g/kg/d *i.g.*, 8 w                                                                    Phosphatidylcholine (PC)↑, sphingomyelin (SM)↓, SM/PC↓, IL-2↑                                                                                                                                                           [@B28]
  CRAB (purity 95.8%)                                                                             C57BL/6 mice; A*β*-induced neurons damage; 10, 50, 100, 150, 250 mg/ml, 24 h                                                                                      Expressions of Phosphorylation of CREB and brain-derived neurotrophic factor (BDNF)↑; The optimal dose: 100 mg/ml                                                                                                       [@B76]
  WRAB (1 g/ml)                                                                                   Male Wister rats; Rat model of VD; 0.3125 ml/100g/d, 28 d                                                                                                         Expressions of MDA↓, SOD↑                                                                                                                                                                                               [@B72]
  WRAB                                                                                            Male Wister rats; AD model induced by A*β*~1-40~ protein and VD model of persistent bilateral ligation of bilateral common carotid arteries; 3.125 g/kg/d, 28 d   IL-4↑, TNF-*α*↓                                                                                                                                                                                                         [@B62]
  RAB extracts of 95% ethanol, petroleum ether, ethyl acetate and petroleum ether-ethyl acetate   SH-SY5Y cells injury induced by hydrogen peroxide, *in vitro*; 10, 50, 100, 250, 500 mg/L, 24 h                                                                   SOD↑, MDA↓, level of BDNF and nerve factor-3↑; The optimal dose of APR 95% ethanol and petroleum ether extracts: 500 mg/L, the optimal dose of APR ethyl acetate and petroleum ether-ethyl acetate extracts: 250 mg/L   [@B22]
  Osthole (\> 98% purity)                                                                         BM-NSCs against injury induced by hydrogen peroxide lactate dehydrogenase leakage, *in vitro*; 0, 10, 50, and 100 µM, 24h                                         The expression ratio of Bcl2-associated X/B-cell lymphoma-2 mRNA↓, increase phosphorylation of CREB and PI3K↑                                                                                                           [@B77]
  **THE EFFECT ON THE CARDIOVASCULAR SYSTEM**                                                                                                                                                                                                                                                                                                                                                                                                                                               
  ARAB                                                                                            MTT, *in vitro*; 3.75, 7.5, 15, 30 μg/ml, 48 h                                                                                                                    HUVEC proliferation, migration and tubule formation↓, HUVEC apoptosis↑                                                                                                                                                  [@B23]
  Osthole                                                                                         MTT, *in vitro*; 3.75, 7.5, 15, 30 μg/ml, 24 h                                                                                                                    HUVEC proliferation, migration and tubule formation↓, HUVEC apoptosis↑                                                                                                                                                  [@B23]
  Osthole (\> 99% purity)                                                                         Male Wister rats, *in vitro*; Isolated pulmonary arteries model; 10^-9^ M to 10^-5^ M                                                                             NO↑, Akt and eNOS↑, phosphorylations of Akt at Phospho-Akt and eNOS at Phospho-eNOS in endothelial cells↑                                                                                                               [@B84]

APR, Angelicae Pubescentis Radix.

Analgesic and Anti-Inflammatory Actions {#s5_1}
---------------------------------------

APR is a high-frequency drug for the treatment of RA, which is an autoimmune disease requiring the use of analgesics and anti-inflammatory medicines to alleviate the associated pain. Some molecules, including extracellular signal-regulated kinase 1/2, arylhydrocarbon receptor, Histone h3, prostaglandin E receptor 2, nuclear factor κappa *β* (NF-*κβ*), programmed cell death 5, interleukin (IL)-36, IL-10, IL-4, Hypoxia Inducible Factor 1A, and arachidonate 15-lipoxygenase, are common molecular targets related to APR and RA, with the Eicosanoid signaling pathway the common pathway of APR and RA ([@B25]).

In TCM, the crude water extract of the root of *A. biserrata* (RAB) is considered a selective and effective herbal agent in attenuating persistent hindpaw inflammation and hyperalgesia in rats ([@B71]). RAB consisting of 60% ethanol extract (1.5 g/kg, *i.g.*) significantly inhibits inflammation in three models, including xylene-induced mouse ear edema test, the mice pettitoes swelling by egg white test and mouse tampon granulation swelling test ([@B34]). However, the methanol-, chloroform-, and ethyl acetate extracts from the root of *A. pubescens* not only effectively reduced pain that was induced by 1% acetic acid and a hot plate, but also reduced the edema that was induced by 3% formalin or 1.5% carrageenan ([@B5]).

The analgesic effect of coumarins isolated from RAB (CRAB, 20 mg/kg, *i.g.*) is mediated by inflammatory factors and transient receptor potential cation channel 1 (TRPV1) as evidenced by a spared nerve injury (SNI) model of neuropathic pain. Molecular profiling has revealed that CRAP reduces levels of the proinflammatory cytokines tumor necrosis factor-*α* (TNF-*α*), IL-1*β*, and IL-6 and significantly attenuates the expressions of TRPV1 and phosphorylated extracellular regulated protein kinases (pERK) in damaged dorsal root ganglion neurons ([@B35]).

Four coumarins (10 mg/kg, *i.p.*), including columbianadin (**40**), columbianetin acetate (**41**), bergapten (**52**) and umbelliferone (**16**), have been demonstrated to have significant anti-inflammatory and analgesic activities. While the coumarins osthole (**17**) and xanthotoxin (**57**) appear to only have anti-inflammatory activity, isoimperatorin (**55**) demonstrates only an analgesic effect. Columbianetin (**43**) inhibits the production of inflammatory cytokines induced by lipopolysaccharide (LPS), which is involved in the downregulation of nucleotide-binding and oligomerization domain 1 (NOD1)/NF-*κβ* pathways ([@B48]). The methanol extract from the root of *A. pubescens* have inhibitory activities on rat hind paw edema induced by carrageenan and on writhing induced by acetic acid in mouse, and the active principle was isolated and identified as osthol ([@B30]). The anti-inflammatory and analgesic constituents from *A. pubescens* appear to be related to the peripheral inhibition of inflammatory substances and to have influences on the central nervous system ([@B5]).

The essential oil from RAB (ERAB) has anti-inflammatory and analgesic effects ([@B13]). The effect of EAPR on inflammation is mediated by the inhibition of N-acylethanolamine-hydrolyzing acid amidase (NAAA) activity, which increases cellular endobioactor N-palmitoylethanolamine (PEA) levels while decreasing proinflammatory factor ([@B57]).

Effects on the Central Nervous System {#s5_2}
-------------------------------------

Brain aging is a neurodegenerative disease, which is incurable debilitating disorders characterized by structural and functional neuronal loss. The primary disease of brain aging is dementia, which includes VD, AD, and a mixed type of both ([@B62]). Free radical damage and immune inflammatory mechanisms have been recognized in current research regarding the mechanisms of brain aging. Because of its large oxygen load, the brain becomes the most vulnerable target of oxygen free radicals, which can damage the central nervous system through a variety of processes, including causing the necrosis or apoptosis of nerve cells ([@B28]).

A water maze test on mice of a D-galactose-induced brain aging model was performed to study the ability of learning and memory ([@B28]). The authors found that RAB and its alcohol extract at 18 mg/kg*/*d can repair the membrane phospholipid structure in different parts of the mouse cerebral cortex and striatum, as well as improve the IL-2 content of aging model mice and resist free radicals and inflammatory damage, thereby improving the learning and memory ability of mice ([@B53]). From the perspective of inhibiting the apoptotic rate of brain tissue cells, the mechanism of RAB water decoction and its alcohol extract in retarding brain aging was revealed.

RAB and/or its water decoction (2 ml/d, *i.g.*) have an inhibitory effect on the inflammatory response of AD model rats induced by Human amyloid beta peptide 1--40 (A*β~1~*~-40~), thus improving the learning and memory ability of AD model rats ([@B95]; [@B88]). The water decoction of RAB (1.08 mg/ml, *i.g.*) can improve the positioning and learning and memory ability of model rats, shortening the time to navigate the water maze ([@B11]). CRAB (purity 95.8%) possess neuroprotective effects in A*β* damaging neuron ([@B76]). In addition, CRAB (purity 72.4%, 14.4 mg/kg, *i.g.*) can significantly protect amyloid precursor protein/presenilin-1 (APP/PS1) mice from neural damage, likely through improving Neurofilament tirplet M expression and reducing apoptotic cells in the brain of APP/PS1 transgenic mice ([@B26]). Moreover, the water decoction of RAB (3.125 g/kg, *i.g.*) can inhibit the expression of malondialdehyde (MDA) in rat serum and increase the activity of Superoxide dismutase (SOD) in order to inhibit free radical damage in VD model rats ([@B72]). Finally, APR has a regulating effect on immune inflammatory injury in AD and VD rats, particularly for the treatment of VD ([@B62]). Extracts, including 95% ethanol, petroleum ether, ethyl acetate, and petroleum ether-ethyl acetate extracts of RAB do not appear to be toxic to SH-SY5Y cells. All of these may increase cell viability and exert antioxidant activity induced by H~2~O~2~ in SH-SY5Y cells, whereas the neuroprotective effects of the petroleum ether-ethyl acetate extract have been shown to be the strongest ([@B22]). Osthole (**17**) protects bone marrow-derived neural stem cells (BM-NSCs) from oxidative damage through the phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt-1) pathway, and it has been shown to improve the inflammatory environment of neurodegenerative diseases and promote the survival rate of transplanted NSCs ([@B77]).

Effects on the Cardiovascular System {#s5_3}
------------------------------------

*γ*-aminobutyric acid (**85**) (10 mg/kg, *i.v.*) isolated from the water extract of RAB (WRAB) showed that it can treat a variety of empirical cardiac arrhythmias, with effects on the action potential of rat neoventricular muscle ([@B32]). The alcohol extract of RAB (ARAB) and WRAB both have anti-angiogenic effects ([@B96]; [@B23]). Osthole (**17**) isolated from ARAB inhibits angiogenesis *in vitro* more strongly than that in the ARAP, indicating that it may be the main antiangiogenic component of ARAB, and its mechanism may be related to the inhibition of human umbilical vein endothelial cell (HUVEC) proliferation, migration and tubule formation, the induction of HUVEC apoptosis, and the arrest of HUVEC cell cycle ([@B23]). ARAB inhibits platelet aggregation and platelet thrombosis in circulating blood ([@B50]; [@B33]). Columbianetin (**43**), columbianetin acetate (**41**), columbianadin (**40**), osthol and columbianetin-*β*-D-glucopyranoside (**44**) also have inhibitory effects on rat platelet aggregation induced by ADP *in vitro* ([@B33]).

Pulmonary arterial hypertension (PAH) is a progressive cardiovascular-disease with high mortality lacking high-efficiency drug. Excitingly, osthole (**17**) extracted from RAB was observed to significantly restore 98 of 315 differential proteins significantly modified by PAH progression ([@B85]). What\'s more, osthole (**17**) extracted from the root of *A. pubescens* has been shown to suppress tracheal smooth muscle contraction, exerting a non-specific relaxant effect on the trachealis by inhibiting cAMP and cGMP phosphodiesterases ([@B59]). However, its dilative effect is dependent on endothelial integrity and NO production, and is mediated by the endothelial PI3K/Akt- endothelial NO synthase (eNOS)-NO pathway ([@B84]). These findings may provide candidates for a new pulmonary vasodilator for the therapy of PAH.

Deworming Activity {#s5_4}
------------------

RAB extracts using different solvents have quite different effects on treating ring worm. ARAB exhibited the best anthelmintic efficacy with 100% mortality of dactylogyrus and no death of the fish at the optimal anthelminthic concentration of 120 mg/L ([@B64]; [@B74]). Osthole (**17**) can reach the 100% parasiticidal rate when the concentration was 1.6 mg/L, with no toxicity to fish at a dose up to 6.2 mg/L. As for scopoletin (**21**), 5 mg/L appears to represent a parasiticidal rate of 74.9% ([@B64]; [@B65]).

Others {#s5_5}
------

Osthole (**17**) also shows osteopromotive effects on osteoblasts both *in vitro* and *in vivo*. Osthole (**17**) -mediated osteogenesis is related to the activation of the cAMP/cAMP response element-binding protein (CREB) signaling pathway and downstream osterix expression ([@B91]). N-hexane and dichloromethane extracts of RAB show inhibitory effects on COX-1 and 5-LO. Linoleic acid appears to be the most active constituent in the extract, exerting COX-1 inhibition, and also has strong inhibitory activity on 5-LO, which is similar to osthole (**17**) ([@B47]).

Pharmacokinetic {#s6}
===============

So far, few pharmacokinetic studies on APR have been done, which mainly focus on coumarins. What\'s more, only medicinal plants *A. biserrata* have been studied. The main pharmacokinetic researches of the extracts or isolated compounds from APR that have been reported studies in animal are discussed below.

Four of the coumarins \[columbianetin acetate (**41**), imperatorin (**54**), isoimperatorin (**55**), and osthole (**17**)\] were rapidly absorbed, while the remaining three coumarins \[psoralen (**51**), bergapten (**52**), and xanthotoxin (**57**)\] were slowly absorbed in rat plasma after oral administration of APR extract (6.0 g/kg) ([@B3]). To assess the brain distributions and blood-brain barrier permeabilities of APR, a UPLC-MS/MS method was applied to the simultaneous determinations of the main coumarins in the rat cerebrospinal fluid (CSF) and brain after oral administration of APR extract (4 g/kg), including psoralen (**51**), xanthotoxin (**57**), bergapten (**52**), isoimperatorin (**55**), columbianetin (**43**), columbianetin acetate (**41**), columbianadin (**40**), oxypeucedanin hydrate (**56**), angelol B (**4**), osthole (**17**), meranzin hydrate (**20**), and nodakenetin (**69**). Most of the tested coumarins entered the rat CSF and brain quickly, and double-peak phenomena in concentration-time curves were similar to those of their plasma pharmacokinetics. Columbianetin (**43**) had the highest concentration in the CSF (C~max~: 485.36 ± 91.40 µg/L, AUC~0→∞~: 4142.82 ± 602.33 µg/L/h) and brain, while psoralen (**51**) and columbianetin acetate (**41**) had the largest percent of CSF/plasma and brain/plasma. ([@B82]). Under the administration mode and dose as above, columbianetin (**43**) was also easier to absorbed compound across caco-2 cell, and also had extremely highest plasma concentration (2000 ng/ml) *in vivo* ([@B81]). The pharmacokinetic properties of columbianetin (**43**) in rat after oral administration were characterized as rapid oral absorption, quick clearance and good absolute bioavailability. Columbianetin (**43**) showed dose proportionality over the dose range 5--20 mg/kg. The bioavailability of columbianetin (**43**) is independent of the doses studied ([@B49]).

The tissues distributions research after oral administration of APR extract (6.0 g/kg) to rat, four coumarins \[columbianetin (**43**), columbianetin acetate, (**41**) osthole (**17)**, columbianadin (**40**)\] were in the liver, followed by the ovary, uterus, kidney, lung, heart, spleen, and muscle ([@B18]). The AUC and C~max~ of bisabolangelone (**80**) after oral administrated pure bisabolangelone (**80**) are higher than those after oral administrated APR extract. Among them, there are significant differences on AUC between pure bisabolangelone (**80**) (7.5 mg/kg *i.g.*) and APR extract (equivalent to bisabolangelone (**80**) at dose of 7.5 mg/kg, *i.g.*). For tissue distribution, the amount of bisabolangelone (**80**) mainly appeared in heart, liver and spleen. Bisabolangelone (**80**) appearance in the brain also revealed that bisabolangelone (**80**) could pass the blood-brain barrier. ([@B17]).

A sensitive LC-MS/MS method has been validated to determine the concentration of columbianadin (**40**) in rat plasma after intravenous administration of columbianadin (**40**) (1, 2.5 and 5 mg/kg). The results show that the distribution half-life (T~1/2α~) were 0.027 0.016, 0.060 0.065, and 0.028 0.023 h, and the elimination half-lives (T~1/2β~) were 0.58 0.20, 0.52 0.25, and 0.52 0.22 h ([@B4]). After oral administration of pure columbianadin (**40**), approximately 0.12% columbianadin (**40**) was transformed into columbianetin (**43**). Oral administration of pure columbianadin (**40**) may be more beneficial for the clinical efficacy of columbianadin (**40**) (25 mg/kg) than APR extract (3.74 g/kg). Pure columbianadin (**40**) group: T~max~: 3.03 ± 1.87 h, C~max~: 1.82 ± 0.64 ng/ml, AUC~(0-tn)~: 1.05 ± 1.02 ng/ml/h; APR extract group: T~max~: 0.55 ± 0.33 h, C~max~: 13.33 ± 25.37 ng/ml, AUC~(0-tn)~: 28.80 ± 41.46 ng/ml/h ([@B36]).

Columbianetin acetate (**41**) and columbianetin-*β*-D-glucopyranoside (**44**, CBG) were rapidly and widely distributed in rats, and eliminated rapidly from plasma. Columbianetin acetate (**41**) could be metabolized into columbianetin (**43**) *in vivo*. Absolute bioavailability of pure columbianetin acetate (**41**) is 7.0 ± 4.3%. Other co-existing ingredients in APR extract could increase the concentration of its metabolite columbianetin (**43**) in plasma and this was caused by CBG (**44**). Cumulative excretion of columbianetin acetate (**41**) in urine accounted for 0.0109 ± 0.0067% of total dosage. The cumulative amounts of columbianetin acetate (**41**) in the feces present 9.32 ± 6.63% of the total dose. Columbianetin acetate (**41**) was mainly excreted in the feces ([@B27]). Besides, CBG (**44**) also could be catabolized into its active metabolite columbianetin (**43**) *in vivo*. The absolute bioavailability of CBG (**44**) was 5.63 ± 4.42%. The other co-existing constituents from the APR ethanol extract could enhance the absorption of CBG (**44**). CBG (**44**) and columbianetin (**43**) were rapidly and broadly distributed in the stomach, ovary, kidney, liver, spleen, lung, muscles, heart and brain. Higher levels of accumulation of CBG (**44**) and columbianetin (**43**) were detected in the ovary and kidney tissues. Eight metabolites of CBG (**44**) were tentatively identified in blood, urine, bile and faeces of rats after oral administration of pure CBG (**44**). It was also found that CBG (**44**) and columbianetin (**43**) were mainly excreted through the faecal route ([@B92]).

Toxicology {#s7}
==========

In ancient and modern books of traditional Chinese medicine including with APR, there was no record of toxicity. The records of toxicity also have not been reported in clinical applications. So far, only a few toxicity tests have been conducted in animals.

In acute toxicity experiments through oral administration, mice of the Kunming species appeared to have cyanosis, agitated activity, and a quickened respiration after 10 min of taking water decoction of APR, and several mice died because of respiratory failure in serious cases. The LD~50~ of mice (*i.g.*) was determined to be 7.35 ± 0.62g**/**kg ([@B12]). In subacute toxicity testing, WAPR has a certain nephrotoxicity, potentially inducing kidney injury through inhibiting organic anion transporters 1 (Oats1), Oat2, Oat3 ([@B6]). WAPR also can cause obvious organ toxicity to juvenile zebrafish, such as yolk sac swelling, deformation, black, pericardial edema, and bleeding, with a minimum lethal dose of 100 μg/ml at 3 days after fertilization in healthy zebrafish embryos ([@B7]). In a 90-days toxicity experiment by mouth, Wistar rats and hybrid dogs were selected. Among them, rats appeared to have cyanosis, agitated activity, and quicken respiration after 10 min of taking APR capsule; however, toxicity symptoms in the rats disappeared after 30 days of taking WAPR. At higher doses of WAPR, the rats grew slower, and pathology inspection revealed gaseous distention in the stomach and edema of mucous membrane. While there were myeline bodies in the liver cells of some rats and dogs, it appeared to be reversible. No differences in the blood and biochemistry indexes of rats and dogs were observed ([@B12]).

Quality Control {#s8}
===============

APR has special aromatous smell, bitter and spicy taste, and makes feeling slightly numbness of tongue. It is traditionally thought that APR with thick and fat branches, strong aroma is of good quality. From the phytochemistry and the pharmacological activity discussed above, coumarins are considered the most important constituents, demonstrating a wide range of pharmacological activities. In Chinese Pharmacopoeia (2015 edition), APR is calculated by dry product, containing osthole (**17**) at not less than 0.50% and columbianadin (**40**) at not less than 0.080%. What\'s more, quality control items for APR in multi-national Pharmacopoeias are listed in [**Table 5**](#T5){ref-type="table"}.

###### 

Quality control items for APR in multi-national Pharmacopoeias.

  Pharmacopoeia                            Identification                                                                                   Water detection or Loss on drying   Ash detection   Determination of content                               
  ---------------------------------------- ------------------------------------------------------------------------------------------------ ----------------------------------- --------------- -------------------------- --------------------------- ----------------------------------------
  Chinese Pharmacopoeia (version 2015)     Fragments identification and TLC                                                                 ≤10%                                ≤8%             ≤3%                        Osthole and columbianadin   The total content≥0.080% (dried drug).
  British Pharmacopoeia (version BP2017)   Microscopic examination and TLC (Reference solution: (Z)-Ligustilide, Osthole and Imperatorin)   ≤10%                                ≤8.0%           ≤3.0%                      Osthole                     The total content≥0.50% (dried drug).
  European Pharmacopoeia (version EP9.3)   Microscopic examination and TLC (Reference solution: (Z)-Ligustilide, Osthole and Imperatorin)   ≤10%                                ≤8.0%           ≤3.0%                      Osthole                     The total content≥0.50% (dried drug).

APR, Angelicae Pubescentis Radix.

APR primarily contains coumarins and volatile oils as the active ingredients ([@B90]). Near IR spectroscopy (NIRs) became a new analysis technique for the quantitative analysis of Chinese medicinal materials because of its rapid analysis speed and no need for sample pretreatment. NIRs also can achieve quantitative analysis for the quality control of osthole (**17**) and columbianadin (**40**) as indicators in APR, except for HPLC ([@B87]). Modern pharmacological research has shown that ferulic acid (**75**) is also the main effective component, providing the effect of activating the blood. However, its content has not been used as an index in Chinese Pharmacopoeia, which is not conducive to the quality control of APR. Therefore, the method for the determination of ferulic acid (**75**) content in APR was established by reverse HPLC ([@B14]). Bisabolangelone (**80**), adenosine (**78**), and 30 coumarins in APR were identified by UPLC-PAD-Q-TOF-MS. The developed method could successfully be used to differentiate samples from different regions and could be a helpful tool for detection and confirmation of the quality of TCM ([@B16]). However, one or several chemical constituents are not the only effective parts of APR. The HPLC fingerprint of APR from different producing areas was constructed with 21 common chromatographic peaks, and the content of columbianetin (**43**), osthole (**17**), isoimperatorin (**55**), and columbianadin (**40**) were determined in APR simultaneously ([@B68]). The GC fingerprint of APR was also established ([@B29]).

Conclusion and Future Perspectives {#s9}
==================================

A significant breakthrough has been made in the last several decades in the areas of phytochemistry and pharmacology of APR. Research on phytochemistry indicated that coumarins and essential oil compounds might be the major active constituents. Crude extracts and pure compounds from the root have been shown to possess multiple biological activities, particularly analgesic and anti-inflammatory actions, as well as effects on the central nervous system. However, further study is still urgently needed to gain a better understanding of APR and its clinical use.

Firstly, 87 compounds, mainly coumarins, have been separated and identified, and more than 100 volatile components have been analyzed by GC-MS, but they were mainly separated from root of *A. biserrata*. Therefore, in further research on the phytochemistry of this plant, more attention should be focused on the others parts, such as rhizome, fruit. Besides, the water-soluble part of APR should be a major focus, because decoction is the main method of administration in the TCM clinic. The majority of pharmacological studies of APR have been conducted using crude and poorly characterized extracts. Thus, bioactivity-guided isolation strategies could be used to study the chemicals underlying the pharmacological activity. To illustrate the scientific significance of medicines\' using, network pharmacology should be used to predict drug targets and the possible molecular mechanisms involved. Then experiments should be further conducted to prove whether the targets and signal path works.

Secondly, studies on pharmacological effects and its mechanisms mainly focus on several coumarins, and the inherent relations between them and the mechanism of treatment of disease have not been explicit enough. More relationships between the chemical composition and pharmacological activity should be established to further explain the principle of disease treatment. Moreover, the pathways of their distribution, absorption, metabolism, and excretion need to be further clarified with pharmacokinetic studies.

Thirdly, records of toxicity were rarely recorded in ancient clinical applications; however, modern pharmacological research has related acute toxicity in animal experiments. Meanwhile, it should be noticed that most pharmacological studies on APR have only been conducted in animal models, cell models, and other *in vitro* experiments. Therefore, comprehensive placebo-controlled and double-blind clinical trials should be undertaken to provide remarkable evidence for these positive findings on the efficacy of APR in the future. In addition, the exact mechanisms of many medicinal properties of this herb still remain vague to date; thus, additional studies to better identify the functions and molecular targets seem to be necessary.

Next, the result of the research on plant resources found that *A. biserrata* had been mistaken as *A. pubescens* in China. At present, *A. pubescens* is only a medicinal plant for local use with a few researches, and the specific difference between the two medicinal plants in clinical use have not been mentioned. In order to standardize the use of traditional Chinese medicine, it is necessary to study the specific differences in the clinical use and pharmacological effect of the two medicinal plants.

Lastly, the natural resources of APR are limited, and the demand is increasing year by year. Since April 2018, the State Administration of Traditional Chinese Medicine of the People\'s Republic of China issued a list of Chinese classical prescriptions (first batch), in which six prescriptions contain APR. This means that the needs of APR will continue to grow. In the course of the determination of the content, our laboratory collected some unqualified cultivation products, so we considered that it might be caused by irregular planting methods. So, the safe, high quality and high efficiency planting technology of this unique living plant needs to be further studied in order to guide the production of TCM.

In summary, APR has been successfully used in clinical practice to treat rheumatic disease as an anodyne for thousands of years. Indeed, modern pharmacological studies have shown that it has effective analgesic and anti-inflammatory actions, as well as effects on the central nervous system. The linkage between traditional uses and modern scientific studies, safety, and efficacy were done on this herb ensuring its clinical use and application.
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